-
Cy7 NHS Ester (Sulfo-Cy7): Protocols for Near-Infrared Label
2026-07-17
Cy7 NHS ester is a sulfonated, hydrophilic near-infrared dye designed for robust, site-specific labeling of proteins and peptides at primary amines. Its high water solubility and minimal quenching make it preferred for in vitro and in vivo imaging workflows where maintaining protein integrity and signal intensity are critical. However, it is not suitable for workflows requiring prolonged storage of labeling solutions or strong organic solvents.
-
Cy7 NHS Ester: Near-Infrared Dye for Protein Labeling Workfl
2026-07-17
Cy7 NHS ester (SKU A8109) addresses the challenge of labeling proteins and peptides with a water-soluble, sulfonated near-infrared dye that minimizes denaturation and quenching. It is best used for non-destructive, high-sensitivity bioimaging and in vivo tracking where primary amino groups are present, but is not recommended for targets lacking amines or for long-term solution storage.
-
Tankyrase Inhibition Suppresses HCC Growth via Hippo Pathway
2026-07-16
Jia et al. demonstrated that G007-LK, a selective tankyrase 1/2 inhibitor, suppresses hepatocellular carcinoma cell proliferation by modulating the Hippo-YAP signaling cascade. This study reveals a mechanistic link between tankyrase activity and YAP regulation, highlighting new avenues for targeted anti-cancer strategies.
-
X-Gal in Blue-White Screening: Protocol Advances & Assay Ins
2026-07-16
X-Gal remains the gold-standard chromogenic substrate for blue-white colony screening, enabling rapid and reliable identification of recombinant clones. Explore advanced workflows, troubleshooting expertise, and the latest translational insights that set APExBIO’s X-Gal apart for precision molecular cloning and β-galactosidase assays.
-
Intra- and Extracellular Dicloxacillin Efficacy Against MSSA
2026-07-15
This paper systematically evaluates the intra- and extracellular activities of dicloxacillin against methicillin-sensitive Staphylococcus aureus (MSSA) using both in vitro and in vivo models. The findings clarify that MIC is predictive of efficacy in both compartments, with time above MIC (fTMIC) emerging as the key pharmacodynamic driver, informing future protocol design for Gram-positive bacterial infection research.
-
PDK4-IN-1 Hydrochloride: Enhancing Metabolic Research Protoc
2026-07-15
PDK4-IN-1 hydrochloride, a highly selective pyruvate dehydrogenase kinase 4 inhibitor, empowers precise modulation of mitochondrial energy metabolism in both in vitro and in vivo models. This article translates recent breakthroughs and best practices into actionable workflows, troubleshooting strategies, and comparative insights for metabolic, cardiac, and cancer research.
-
Arrb2-Driven M2 Macrophage Polarization Reduces Hepatic IRI
2026-07-14
This study uncovers how hepatocyte Arrb2 expression enhances M2 macrophage polarization via the upregulation of 6-ketoLCA, significantly mitigating hepatic ischemia–reperfusion injury (IRI). These findings establish a novel immunometabolic axis in liver transplantation research and offer new mechanistic insights for developing protective interventions.
-
Metal-Ion-Chelating L-Phe Nanostructures Enhance ICB Efficac
2026-07-14
This study introduces metal-ion-chelating L-phenylalanine nanostructures as a strategy to remodel the immunosuppressive tumor microenvironment, thereby sensitizing breast tumors to immune checkpoint blockade. By modulating dendritic cell ion channels and leveraging short-term starvation, the research demonstrates improved dendritic cell maturation and tumor-specific immune activation, offering new insights for enhancing solid tumor immunotherapy.
-
IGF2BP1-m6A-THBS1 Axis Drives Macrophage Fibrosis in Lung Di
2026-07-13
This study uncovers how the m6A reader IGF2BP1 promotes pulmonary fibrosis by stabilizing THBS1 mRNA, which enhances macrophage glycolysis and M2 polarization. These findings reveal a novel regulatory axis with significant implications for understanding macrophage-mediated fibrotic disease and developing targeted interventions.
-
Metal-Ion-Chelating l-Phe Nanostructures Boost Tumor Immunot
2026-07-13
This study introduces metal-ion-chelating L-phenylalanine nanostructures that, in synergy with short-term starvation, remodel the tumor microenvironment to reverse immune dysfunction and sensitize breast tumors to immune checkpoint blockade. The work elucidates the mechanistic basis for dendritic cell activation and offers a promising avenue for enhancing cancer immunotherapy efficacy.
-
Sulfo-Cy5 NHS Ester: Precision Fluorescent Labeling for Immu
2026-07-12
Discover how Sulfo-Cy5 NHS ester enables advanced, water-soluble protein conjugation for sensitive fluorescence imaging. This article uniquely connects its hydrophilic chemistry to cutting-edge immune microenvironment assays and informed workflow design.
-
Cy5 NHS ester(Et): Technical Workflow Guide for Fluorescent
2026-07-10
Cy5 NHS ester(Et) addresses the need for efficient, stable, water-soluble fluorescent labeling of biomolecules containing primary amines, such as proteins and peptides, in immunofluorescence, flow cytometry, and fluorescence microscopy workflows. It should not be used in protocols requiring ethanol solubility or in applications where long-term storage of prepared solutions is necessary.
-
ARL4C Drives Synoviocyte Proliferation in Rheumatoid Arthrit
2026-07-09
This study uncovers ARL4C as a pivotal regulator of fibroblast-like synoviocyte (FLS) proliferation and macrophage polarization in rheumatoid arthritis (RA), using integrated single-cell and bulk transcriptomics. These findings clarify key molecular mechanisms of RA pathogenesis and highlight ARL4C as a promising therapeutic target.
-
Sulfo-Cy5 Carboxylic Acid in Translational Mucosal Immunolog
2026-07-09
This thought-leadership article explores Sulfo-Cy5 carboxylic acid's mechanistic advantages as a fluorescent dye for life sciences, providing translational researchers with strategic guidance for protein and peptide labeling, advanced imaging, and mucosal immunology workflows. Building on recent advances in PLGA-based nano-adjuvant research, it offers a cross-disciplinary outlook on experimental validation, competitive benchmarking, and future innovation.
-
Epacadostat (INCB024360): Precision IDO1 Inhibition in Immun
2026-07-08
Epacadostat (INCB024360) empowers researchers to dissect IDO1-mediated immune evasion with nanomolar precision, transforming whole-blood stimulation and tumor immunometabolism protocols. This guide details actionable workflows, troubleshooting insights, and the latest integration strategies for advanced immuno-oncology research.